JR
Jai Rijhwani
About Jai Rijhwani
Data last updated:
Jai Rijhwani has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Cannyco Foodworks Private Limited and Nexacare Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Nexacare Lifesciences Private Limited at ₹1.03 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Sep 2024 | 2016 | ₹1.03 Cr (FY 2025) | Active | |
| Director | 29 Mar 2022 | 2022 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jai Rijhwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jai Rijhwani
Jai Rijhwani has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Cannyco Foodworks Private Limited and Nexacare Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Nexacare Lifesciences Private Limited at ₹1.03 Cr (FY 2025).
Jai Rijhwani is associated with 2 companies as Director, including Nexacare Lifesciences Private Limited (₹1.03 Cr), Cannyco Foodworks Private Limited.
Jai Rijhwani has expertise in General Business.
Jai Rijhwani has 4 years in corporate governance.
By reported revenue, the largest current company of Jai Rijhwani is Nexacare Lifesciences Private Limited, with revenue of ₹1.03 Cr (FY 2025).
Jai Rijhwani currently holds positions at 2 companies: Nexacare Lifesciences Private Limited (₹1.03 Cr), Cannyco Foodworks Private Limited.